Cadrenal Therapeutics
CVKD · NASDAQ
$1.04−$0.02 (−1.89%)TodayMarket closed ·
Prev close $1.06
Who owns CVKD
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 24.5% of CVKD’s shares.
- PNC Investments LLC7.5%
- The PVBQ Living Trust6.5%
- Pham (Quang X)3.2%
- Havlickova 648 as2.5%
- Next 6 largest institutions4.9%
- All other shareholders75.5%
| Holder | Shares | % of shares |
|---|---|---|
| PNC Investments LLC | 233.22K | 7.52% |
| The PVBQ Living Trust | 200.00K | 6.45% |
| Pham (Quang X) | 98.59K | 3.18% |
| Havlickova 648 as | 78.29K | 2.53% |
| Vanguard Capital Management, LLC | 50.14K | 1.62% |
| Murphy (John Raymond) | 40.99K | 1.32% |
| HRT Financial LP | 29.05K | 0.94% |
| Geode Capital Management, L.L.C. | 19.02K | 0.61% |
| Vanguard Fiduciary Trust Co | 8.31K | 0.27% |
| Wilson (Glynn) | 3.33K | 0.11% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 33.28K | 1.07% |
| Vanguard Extended Market Index Fund | 16.86K | 0.54% |
| Fidelity Extended Market Index Fund | 12.31K | 0.40% |
| Fidelity Series Total Market Index Fund | 2.45K | 0.08% |
| Fidelity NASDAQ Composite Index Fund | 2.04K | 0.07% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders sold $388.29K (22 trades) of CVKD on the open market, with no buys.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Cole Jeffrey Scott | Award | 150.00K | — |
| Golden Lee Scott | Award | 75.00K | — |
| WILSON GLYNN | Award | 75.00K | — |
| Pham Quang X | Award | 200.00K | — |
| MURPHY JOHN RAYMOND | Award | 75.00K | — |
| Pham Quang X | Sale | 7.40K | $22.42K |
| Pham Quang X | Sale | 9.03K | $27.54K |
| Pham Quang X | Sale | 2.13K | $6.38K |
| Pham Quang X | Sale | 2.28K | $7.29K |
| Pham Quang X | Sale | 9.17K | $32.54K |
Short interest
Settled Sep 30, 2026
- Shares short
- 105.94K
- Days to cover
- 1.08
- % of shares outstanding
- 3.42%
- Average daily volume
- 98.17K
- Change since last report
- −10.8%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.